Association of the British Pharmaceutical Industry
@abpi.bsky.social
Medicines and vaccines are transforming our lives like never before. We represent the companies that make them possible. 📨 [email protected]
Acid Sphingomyelinase Deficiency (ASMD) is a rare disease that shortens the lives of children & adults.
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
November 26, 2025 at 10:52 AM
Acid Sphingomyelinase Deficiency (ASMD) is a rare disease that shortens the lives of children & adults.
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Treatments can halt symptoms & reverse disease progression, but many UK patients cannot access these medicines, even though they are available in over 50 countries.
www.ourcommongoal.org.uk
Sepsis is the body's reaction to a serious infection and is responsible thousands of deaths a year.
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
November 24, 2025 at 11:55 AM
Sepsis is the body's reaction to a serious infection and is responsible thousands of deaths a year.
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Antibiotics are essential for treating #sepsis but rising resistance means we must find new ones.
Learn more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025
Treating pneumonia without antibiotics is like a hot-air balloon without gas.
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
November 21, 2025 at 12:41 PM
Treating pneumonia without antibiotics is like a hot-air balloon without gas.
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
This week is World Antimicrobial Awareness Week and we’re highlighting how #AntimicrobialResistance remains a threat to modern medicine as we know it.
www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW2025
NHS patients with blood cancer can only access half the approved medicines for their condition despite many of these treatments being available in other countries
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
November 21, 2025 at 11:23 AM
NHS patients with blood cancer can only access half the approved medicines for their condition despite many of these treatments being available in other countries
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
The question: will the UK continue to leave blood cancer patients behind or give them access to new treatments? www.ourcommongoal.org.uk
Treatments for kidney disease are under threat from antibiotic resistance.
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
November 19, 2025 at 11:47 AM
Treatments for kidney disease are under threat from antibiotic resistance.
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
Without antibiotics, procedures like dialysis become far riskier.
Find out more: www.togetherforantibiotics.org.uk
#TogetherForAntibiotics #WAAW #WAAW2025 #AMR
ABPI Wales Head of External Affairs Joe Castle was joined by the Welsh First Minister @ the Senedd to discuss joint @welshnhsconfed.bsky.social guidance covering how industry & the NHS can work together to improve patient outcomes & support innovation across Wales.
www.nhsconfed.org/publications...
www.nhsconfed.org/publications...
November 18, 2025 at 4:15 PM
ABPI Wales Head of External Affairs Joe Castle was joined by the Welsh First Minister @ the Senedd to discuss joint @welshnhsconfed.bsky.social guidance covering how industry & the NHS can work together to improve patient outcomes & support innovation across Wales.
www.nhsconfed.org/publications...
www.nhsconfed.org/publications...
What if our treatments no longer worked?
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
November 18, 2025 at 11:19 AM
What if our treatments no longer worked?
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
Antibiotics are one of the most powerful tools in healthcare.
But resistance to them is rising.
Learn more: togetherforantibiotics.org.uk
#WAAW #WAAW2025 #AMR
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK, even though people in the US and many European countries can access them.
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
November 11, 2025 at 10:45 AM
New breast cancer treatments can extend patients’ lives, yet some remain unavailable in parts of the UK, even though people in the US and many European countries can access them.
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
Will the UK invest in cutting-edge therapies, or deny them to patients?
www.ourcommongoal.org.uk/breast-cancer/
We’re celebrating #BiologyWeek! 🎉
A biology background can lead to many careers in the pharmaceutical industry.
Remi Goldsmith helps shape policies that help researchers turn scientific ideas into future treatments.
www.abpi.org.uk/careers/job-... #iamabiologist @rsb.org.uk
A biology background can lead to many careers in the pharmaceutical industry.
Remi Goldsmith helps shape policies that help researchers turn scientific ideas into future treatments.
www.abpi.org.uk/careers/job-... #iamabiologist @rsb.org.uk
October 17, 2025 at 11:30 AM
We’re celebrating #BiologyWeek! 🎉
A biology background can lead to many careers in the pharmaceutical industry.
Remi Goldsmith helps shape policies that help researchers turn scientific ideas into future treatments.
www.abpi.org.uk/careers/job-... #iamabiologist @rsb.org.uk
A biology background can lead to many careers in the pharmaceutical industry.
Remi Goldsmith helps shape policies that help researchers turn scientific ideas into future treatments.
www.abpi.org.uk/careers/job-... #iamabiologist @rsb.org.uk
Caleb Meath helps to develop policies that allow researchers in the pharmaceutical industry to use health data to improve patient care.
Find out more about careers in the pharmaceutical industry: www.abpi.org.uk/careers/job-...
#IAmABiologist #BiologyWeek
Find out more about careers in the pharmaceutical industry: www.abpi.org.uk/careers/job-...
#IAmABiologist #BiologyWeek
October 16, 2025 at 4:14 PM
Caleb Meath helps to develop policies that allow researchers in the pharmaceutical industry to use health data to improve patient care.
Find out more about careers in the pharmaceutical industry: www.abpi.org.uk/careers/job-...
#IAmABiologist #BiologyWeek
Find out more about careers in the pharmaceutical industry: www.abpi.org.uk/careers/job-...
#IAmABiologist #BiologyWeek
This week is the Royal Society of Biology's #BiologyWeek which highlights the value of a bioscience degrees, what they can lead to.
There is a wide range of career paths available in the pharmaceutical industry - find out more about careers: www.abpi.org.uk/careers/job-...
#iamabiologist
There is a wide range of career paths available in the pharmaceutical industry - find out more about careers: www.abpi.org.uk/careers/job-...
#iamabiologist
October 15, 2025 at 3:37 PM
This week is the Royal Society of Biology's #BiologyWeek which highlights the value of a bioscience degrees, what they can lead to.
There is a wide range of career paths available in the pharmaceutical industry - find out more about careers: www.abpi.org.uk/careers/job-...
#iamabiologist
There is a wide range of career paths available in the pharmaceutical industry - find out more about careers: www.abpi.org.uk/careers/job-...
#iamabiologist
Published for #NICON25 - guidance from us and @niconfederation.bsky.social on creating successful NHS-industry partnerships.
Together we will harness the power of partnership to improve care and deliver lasting value for people, systems, and society. #PowerofPartnerships
bit.ly/4nV2Mp4
Together we will harness the power of partnership to improve care and deliver lasting value for people, systems, and society. #PowerofPartnerships
bit.ly/4nV2Mp4
October 15, 2025 at 3:18 PM
Published for #NICON25 - guidance from us and @niconfederation.bsky.social on creating successful NHS-industry partnerships.
Together we will harness the power of partnership to improve care and deliver lasting value for people, systems, and society. #PowerofPartnerships
bit.ly/4nV2Mp4
Together we will harness the power of partnership to improve care and deliver lasting value for people, systems, and society. #PowerofPartnerships
bit.ly/4nV2Mp4
We're very pleased to be supporting the #NICON25 conference - now underway! @niconfederation.bsky.social
By harnessing the strength of the health service, the life sciences sector, and Northern Ireland’s academic prowess, we can deliver for patients.
By harnessing the strength of the health service, the life sciences sector, and Northern Ireland’s academic prowess, we can deliver for patients.
October 15, 2025 at 11:57 AM
We're very pleased to be supporting the #NICON25 conference - now underway! @niconfederation.bsky.social
By harnessing the strength of the health service, the life sciences sector, and Northern Ireland’s academic prowess, we can deliver for patients.
By harnessing the strength of the health service, the life sciences sector, and Northern Ireland’s academic prowess, we can deliver for patients.
Joanna Jenkinson leads on research and development policy at the ABPI, from discovery science & pre-clinical all the way through to clinical research and development, including emerging technologies and innovative R&D design.
www.abpi.org.uk/careers/job-...
#iamabiologist @rsb.org.uk #BiologyWeek
www.abpi.org.uk/careers/job-...
#iamabiologist @rsb.org.uk #BiologyWeek
October 14, 2025 at 3:00 PM
Joanna Jenkinson leads on research and development policy at the ABPI, from discovery science & pre-clinical all the way through to clinical research and development, including emerging technologies and innovative R&D design.
www.abpi.org.uk/careers/job-...
#iamabiologist @rsb.org.uk #BiologyWeek
www.abpi.org.uk/careers/job-...
#iamabiologist @rsb.org.uk #BiologyWeek
This week we are celebrating #BiologyWeek, highlighting the varied career paths Biology background can lead you to within the pharmaceutical industry.
Find out more about careers in the pharmaceutical industry: lnkd.in/gQGgd5KM
#iamabiologist @rsb.org.uk
Find out more about careers in the pharmaceutical industry: lnkd.in/gQGgd5KM
#iamabiologist @rsb.org.uk
October 13, 2025 at 2:25 PM
This week we are celebrating #BiologyWeek, highlighting the varied career paths Biology background can lead you to within the pharmaceutical industry.
Find out more about careers in the pharmaceutical industry: lnkd.in/gQGgd5KM
#iamabiologist @rsb.org.uk
Find out more about careers in the pharmaceutical industry: lnkd.in/gQGgd5KM
#iamabiologist @rsb.org.uk
#CPC25 discussions about industrial strategy.
Lord Willet's Chair of the Resolution Foundation and Chair of the Regulatory Innovation Office has recognised how important regulation is to growth and investors.
Read our report on Regulation: www.abpi.org.uk/publications...
Lord Willet's Chair of the Resolution Foundation and Chair of the Regulatory Innovation Office has recognised how important regulation is to growth and investors.
Read our report on Regulation: www.abpi.org.uk/publications...
October 6, 2025 at 3:53 PM
#CPC25 discussions about industrial strategy.
Lord Willet's Chair of the Resolution Foundation and Chair of the Regulatory Innovation Office has recognised how important regulation is to growth and investors.
Read our report on Regulation: www.abpi.org.uk/publications...
Lord Willet's Chair of the Resolution Foundation and Chair of the Regulatory Innovation Office has recognised how important regulation is to growth and investors.
Read our report on Regulation: www.abpi.org.uk/publications...
Great session with @astra-zeneca.bsky.social UK today at #CPC25 on the potential of life sciences.
For Shadow Health Minister Dr Caroline Johnson, important recognition that we need to get new medicines to patients quicker.
For Shadow Health Minister Dr Caroline Johnson, important recognition that we need to get new medicines to patients quicker.
October 6, 2025 at 3:49 PM
Great session with @astra-zeneca.bsky.social UK today at #CPC25 on the potential of life sciences.
For Shadow Health Minister Dr Caroline Johnson, important recognition that we need to get new medicines to patients quicker.
For Shadow Health Minister Dr Caroline Johnson, important recognition that we need to get new medicines to patients quicker.
For Health Minister @ashleydaltonmp.bsky.social, vaccination sits across all three shifts in the #NHS10YearPlan.
"We need to be in communities, that's why the neighbourhood health service will be so important."
#LabourConference2025 @ippr.org @age-uk.bsky.social
"We need to be in communities, that's why the neighbourhood health service will be so important."
#LabourConference2025 @ippr.org @age-uk.bsky.social
September 29, 2025 at 10:35 AM
For Health Minister @ashleydaltonmp.bsky.social, vaccination sits across all three shifts in the #NHS10YearPlan.
"We need to be in communities, that's why the neighbourhood health service will be so important."
#LabourConference2025 @ippr.org @age-uk.bsky.social
"We need to be in communities, that's why the neighbourhood health service will be so important."
#LabourConference2025 @ippr.org @age-uk.bsky.social
At #Lab25, our President Russell Abberley is discussing the future of UK vaccination policy with @ashleydaltonmp.bsky.social, Darius Hughes of Moderna,
Caroline Abrahams of @age-uk.bsky.social & Sebastian Rees of @ippr.org
Caroline Abrahams of @age-uk.bsky.social & Sebastian Rees of @ippr.org
September 29, 2025 at 10:23 AM
At #Lab25, our President Russell Abberley is discussing the future of UK vaccination policy with @ashleydaltonmp.bsky.social, Darius Hughes of Moderna,
Caroline Abrahams of @age-uk.bsky.social & Sebastian Rees of @ippr.org
Caroline Abrahams of @age-uk.bsky.social & Sebastian Rees of @ippr.org
At #Lab25 we have been discussing innovation, life sciences & the #NHS10YearPlan, hosted by
@labourtogether.bsky.social
@steveyemm-mp.bsky.social highlighted challenges being faced by industry, and said it is vital that government addresses those to deliver for patients.
@labourtogether.bsky.social
@steveyemm-mp.bsky.social highlighted challenges being faced by industry, and said it is vital that government addresses those to deliver for patients.
September 29, 2025 at 8:47 AM
At #Lab25 we have been discussing innovation, life sciences & the #NHS10YearPlan, hosted by
@labourtogether.bsky.social
@steveyemm-mp.bsky.social highlighted challenges being faced by industry, and said it is vital that government addresses those to deliver for patients.
@labourtogether.bsky.social
@steveyemm-mp.bsky.social highlighted challenges being faced by industry, and said it is vital that government addresses those to deliver for patients.
ICYMI: @torbett.bsky.social spoke to BBC Business earlier about investment in medicines.
The UK spends just 9% of the NHS budget on medicines. For most of Europe it's 14% - 20%.
This gap leaves the UK at risk of missing out on investment.
We believe it is possible to find a solution. 👇
The UK spends just 9% of the NHS budget on medicines. For most of Europe it's 14% - 20%.
This gap leaves the UK at risk of missing out on investment.
We believe it is possible to find a solution. 👇
September 25, 2025 at 11:59 AM
ICYMI: @torbett.bsky.social spoke to BBC Business earlier about investment in medicines.
The UK spends just 9% of the NHS budget on medicines. For most of Europe it's 14% - 20%.
This gap leaves the UK at risk of missing out on investment.
We believe it is possible to find a solution. 👇
The UK spends just 9% of the NHS budget on medicines. For most of Europe it's 14% - 20%.
This gap leaves the UK at risk of missing out on investment.
We believe it is possible to find a solution. 👇
🧵The UK is fortunate to have an excellent science base which continues to offer world-class scientific expertise and globally respected academic institutions.
It is also one of the world’s most vibrant environments for biotech and spinout companies. (1/2)
It is also one of the world’s most vibrant environments for biotech and spinout companies. (1/2)
September 17, 2025 at 10:39 AM
🧵The UK is fortunate to have an excellent science base which continues to offer world-class scientific expertise and globally respected academic institutions.
It is also one of the world’s most vibrant environments for biotech and spinout companies. (1/2)
It is also one of the world’s most vibrant environments for biotech and spinout companies. (1/2)
But while investment in the UK has grown in recent years, we’re lagging behind our global peers. Other countries are making bold moves to attract more life sciences investment – and the UK risks falling behind unless action is taken. (2/3)🧵
September 11, 2025 at 7:40 AM
But while investment in the UK has grown in recent years, we’re lagging behind our global peers. Other countries are making bold moves to attract more life sciences investment – and the UK risks falling behind unless action is taken. (2/3)🧵
The pharmaceutical industry invests more in R&D than any other sector – driving the discovery of new medicines and vaccines that improve health outcomes for patients and strengthen the UK economy. (1/3)🧵
September 11, 2025 at 7:39 AM
The pharmaceutical industry invests more in R&D than any other sector – driving the discovery of new medicines and vaccines that improve health outcomes for patients and strengthen the UK economy. (1/3)🧵
Our Chief Exec @torbett.bsky.social spoke to Times Radio about medicine rebates.
The government's offer would still mean the industry paying £13 billion back to government over 3 years - 3 times more than any other European country.
We could not accept that, but hope to continue discussions.
The government's offer would still mean the industry paying £13 billion back to government over 3 years - 3 times more than any other European country.
We could not accept that, but hope to continue discussions.
August 26, 2025 at 12:39 PM
Our Chief Exec @torbett.bsky.social spoke to Times Radio about medicine rebates.
The government's offer would still mean the industry paying £13 billion back to government over 3 years - 3 times more than any other European country.
We could not accept that, but hope to continue discussions.
The government's offer would still mean the industry paying £13 billion back to government over 3 years - 3 times more than any other European country.
We could not accept that, but hope to continue discussions.